2024-520077-12-00招募中1 期
A Study of NTX-1088 as Monotherapy and Combined with Pembrolizumab
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 10
- 试验地点
- 1
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（18-64 Years, 65+ Years）
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
Chief Development Officer
Scientific
Nectin Therapeutics Ltd.
研究点 (1)
Loading locations...
相似试验
招募中
1 期
KO-2806 Monotherapy and Combination Therapies in Advanced Solid TumorsRenal Cell CarcinomaColorectal Cancer2024-513285-19-00Kura Oncology Inc.68
已完成
1 期
Study to Evaluate the Safety and Efficacy of Treatment with NLM-001 before Standard Chemotherapy plus Zalifrelimab in Patients with Advanced Pancreatic Cancer2024-518852-22-00Nelum Corp.28
已完成
1 期
A research study of a new medicine (NNC0650-0013) in healthy men2023-506134-79-00Novo Nordisk A/S60
招募中
1 期
A trial to investigate the safety and pharmacokinetics of GRT6019 in healthy male participants.2025-523587-20-00Gruenenthal GmbH24
已完成
1 期
Effects of NT-0796 in Healthy Volunteers and Patients with Parkinson’s DiseaseParkinson's Disease2023-503203-29-00Nodthera Limited14